OPT
Click for more information
1.39% 35.5¢ opthea limited

Ann: Opthea Completes Enrollment in First Trial of Sozinibercept, page-8

  1. simons77
    620 Posts.
    lightbulb Created with Sketch. 155
    clock Created with Sketch.
    15/02/24
    10:47
    Post #: 72418626
    that mean we wont see fda approval until 2027.... more diluation
    OPT Price at posting: 59.0¢ Sentiment: Sell Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
GYG Guzman Y Gomez shot up nearly 40% in first hour of trades. Can it last?
right-arrow Created with Sketch.
FHE Frontier Energy achieves key milestone for Waroona energy project
right-arrow Created with Sketch.
NEWS From the Floor question: "Is lithium dead?"
right-arrow Created with Sketch.
HAR Haranga resource upgrade builds confidence in Saraya uranium project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add OPT (ASX) to my watchlist
(20min delay)
Last
35.5¢ 		Change
-0.005(1.39%) 		Mkt cap ! $387.4M
Open High Low Value Volume
36.0¢ 36.0¢ 35.5¢ $632.4K 1.766M

Buyers (Bids)

No. Vol. Price($)
11 361309 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 38071 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.